Erlotinib for Squamous Cell Carcinoma of the Lung A Prospective Phase II Study

被引:0
|
作者
Kim, Eun Kyoung [1 ]
Choi, Chang-Min [1 ]
Lee, Dae Ho [1 ]
Choi, Jene [2 ]
Jang, Se Jin [2 ]
Suh, Cheolwon [1 ]
Lee, Jung Shin [1 ]
Kim, Sang-We [1 ]
机构
[1] Asan Med Ctr, Dept Oncol, Asan, South Korea
[2] Asan Med Ctr, Dept Pathol, Asan, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S399 / S399
页数:1
相关论文
共 50 条
  • [1] A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
    Zhao, Chuanhua
    Lin, Li
    Liu, Jianzhi
    Liu, Rongrui
    Chen, Yuling
    Ge, Feijiao
    Jia, Ru
    Jin, Yang
    Wang, Yan
    Xu, Jianming
    ONCOTARGET, 2016, 7 (35) : 57310 - 57316
  • [2] Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva
    Horowitz, N. S.
    Olawaiye, A. B.
    Borger, D. R.
    Growdon, W. B.
    Krasner, C. N.
    Matulonis, U. A.
    Liu, J. F.
    Lee, J.
    Brard, L.
    Dizon, D. S.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : 141 - 146
  • [3] Phase II trial of erlotinib (Tarceva) in women with squamous cell carcinoma of the vulva
    Horowitz, N.
    Olawaiye, A.
    Growdon, W.
    Borger, D.
    Dizon, D.
    Brard, L.
    Matulonis, U.
    MacNeill, K.
    Roche, M.
    Krasner, C.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S14 - S14
  • [4] Erlotinib in patients with advanced lung squamous cell carcinoma
    Chiang, Chi-Lu
    Tsai, Chun-Ming
    Chou, Teh-Ying
    Chen, Yuh-Min
    Lai, Shinn-Liang
    Shih, Jen-Fu
    Chiu, Chao-Hua
    Lee, Yu-Chin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 203 - 208
  • [5] Erlotinib in patients with advanced lung squamous cell carcinoma
    Chi-Lu Chiang
    Chun-Ming Tsai
    Teh-Ying Chou
    Yuh-Min Chen
    Shinn-Liang Lai
    Jen-Fu Shih
    Chao-Hua Chiu
    Yu-Chin Lee
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 203 - 208
  • [6] A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study
    Schilder, Russell J.
    Sill, Michael W.
    Lee, Yi-Chun
    Mannel, Robert
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 929 - 933
  • [7] Erlotinib for Pretreated Squamous Cell Carcinoma of the Lung in Japanese Patients
    Hata, Akito
    Katakami, Nobuyuki
    Kunimasa, Kei
    Yoshioka, Hiroshige
    Fujita, Shiro
    Kaji, Reiko
    Tachikawa, Ryo
    Tomii, Keisuke
    Imai, Yukihiro
    Iwasaku, Masahiro
    Ishida, Tadashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (12) : 1366 - 1372
  • [8] ERLOTINIB FOR JAPANESE PATIENTS WITH RELAPSED SQUAMOUS CELL CARCINOMA OF THE LUNG
    Hata, Akito
    Kei, Kunimasa
    Hiroshige, Yoshioka
    Shiro, Fujita
    Reiko, Kaji
    Ryo, Tachikawa
    Keisuke, Tomii
    Tadashi, Ishida
    Nobuyuki, Katakami
    RESPIROLOGY, 2010, 15 : 71 - 71
  • [9] Erlotinib in patients with advanced squamous cell carcinoma of the lung.
    Gúrpide, A.
    Massuti, B.
    Pallares, C.
    Salinas, P.
    Montes, A.
    López-Vivanco, G.
    Barón, M. González
    Cobo, M.
    Amador, M. L.
    Paz-Ares, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 407S - 407S
  • [10] Phase II study of nedaplatin and docetaxel in patients with advanced squamous cell carcinoma of the lung
    Naito, Y.
    Kubota, K.
    Ohmatsu, H.
    Goto, K.
    Niho, S.
    Yoh, K.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2011, 22 (11) : 2471 - 2475